Abstract:Background Cervical cancer, which is a significant public health concern in women, currently lacks effective therapeutic drugs. Matrine, a constituent of the traditional Chinese herb Sophora flavescentis Radix , is known for its anti-cervical cancer properties and ability to induce programmed cell death. The induction of cancer cell ferroptosis, which is a novel cell death pattern, can become an effective clinical therapy for tumor in the future. However, the effect of matrine on ferroptosis in cervical cancer remains to be elucidated. Purpose In this study, we investigated whether matrine induces ferroptosis in cervical cancer and elucidated the underlying mechanisms. Methods We established an SiHa-derived tumor-bearing mouse model using CB17 severe combined immunodeficient (SCID) mice and administered a group of matrine (25, 50, and 75 mg/kg) and cisplatin (2 mg/kg). We meticulously tracked alterations in body weight and tumor size and evaluated liver and kidney health using haematoxylin and eosin (H&E) staining. Using Gene Expression Omnibus (GEO) Dataset (GSE201309), we evaluated the relationship between the effects of matrine on malignant tumor cells and ferroptosis. In vitro , tetrazolium-based colorimetric (MTT), lactate dehydrogenase (LDH) and colony formation assays were used to study the effects of matrine on SiHa cell activity and cytotoxicity. We assessed ferroptosis-related protein abundance using western blotting and ferroptosis-related indices in cells using confocal immunofluorescence microscopy. The interaction of matrine with a protein linked to ferroptosis was studied using cellular thermal shift assay (CETSA). The effects of matrine on Piezo1 expression were investigated using calcium imaging. We also used Piezo1-specific siRNA to explore the role of Piezo1 in ferroptosis. Results Matrine administration effectively inhibited tumor growth in a SiHa-derived tumor-bearing mouse model without inducing noticeable harm. The analysis results of GEO data set show matrine-induced effects in tumor cells were indeed involved in the process of ferroptosis. Treatment with matrine resulted in a significant reduction in GPX4 protein levels and a concurrent increase in lipid peroxide and Fe 2+ content, suggesting matrine-induced modulation of ferroptosis. Matrine promoted SiHa cell death in vitro , as evidenced by the results of MTT and LDH assays. Cell death coincides with increases in intracellular Fe 2+ , reactive oxygen species (ROS), and lipid peroxides. Our study also revealed significant upregulation of Piezo1 expression through the action of matrine, whereas transferrin receptor (Tfr) and System Xc- (xCT) expression and interaction remained unaffected. We provided further evidence that matrine induces calcium influx through the Piezo1 channel, thereby potentially influencing ferroptosis. Transfection with Piezo1 siRNA reversed the effects of matrine in SiHa cell. Conclusions Our findings indicate that matrine exerts a protective effect against cervical cancer by inducing ferroptosis through the activation of Piezo1, but not xCT or Tfr.

Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt/mTOR pathway in vitro and in vivo

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Autophagy is Involved in Anticancer Effects of Matrine on SGC-7901 Human Gastric Cancer Cells.

Protective Role of Autophagy in Matrine-Induced Gastric Cancer Cell Death

Antitumor Effect of Matrine in Human Hepatoma G2 Cells by Inducing Apoptosis and Autophagy.

Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases.

Matrine Inhibits Proliferation and Induces Apoptosis Via BID-mediated Mitochondrial Pathway in Esophageal Cancer Cells

Matrine induces autophagic cell death by triggering ROS/AMPK/mTOR axis and apoptosis in multiple myeloma

Effects of matrine in combination with cisplatin on liver cancer

Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways

Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-κB signaling

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Matrine Inhibits Proliferation and Induces Apoptosis of Pancreatic Cancer Cells in Vitro and in Vivo.

Matrine Alters Microrna Expression Profiles in SGC-7901 Human Gastric Cancer Cells.

Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway.

Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel

Matrine Induces the Apoptosis of Lung Cancer Cells Through Downregulation of Inhibitor of Apoptosis Proteins and the Akt Signaling Pathway

Matrine Inhibits the Proliferation and Migration of Lung Cancer Cells Through Regulation of the Protein Kinase B/glycogen Synthase Kinase-3Β Signaling Pathways.

Matrine Induces Apoptosis in Gastric Carcinoma Cells Via Alteration of Fas/FasL and Activation of Caspase-3

Anticancer Effect of a Combination of Cisplatin and Matrine on Cervical Cancer U14 Cells and U14 Tumor-Bearing Mice, and Possible Mechanism of Action Involved

Effects of Matrine on the Proliferation of HT29 Human Colon Cancer Cells and Its Antitumor Mechanism.